IL37 and hepatocellular carcinoma: By contrast to gastric cancer, it has been reported that IL-37 suppresses hepatocellular carcinoma (HCC) growth through inhibiting tumor-associated macrophages (TAM) (54), by promoting TAM polarization from the pro-tumorigenic M2 subtype to the anti-tumorigenic M1 subtype (55).